Table 2.
MIC50, MIC90 of tested C. difficile strains.
| Antibiotic | MIC50 | MIC90 | Strains resistant | Breakpoints used [mg/L] | |
|---|---|---|---|---|---|
| n = 130 | % | ||||
| Metronidazolea | 1 | 2 | 5 | 4 | S ≤ 2, R > 2 |
| Vancomycina | 0.38 | 0.5 | 0 | 0 | S ≤ 2, R > 2 |
| Erythromycinb | 256 | 256 | 87 | 67 | R > 256 |
| Clindamycind | 8 | 256 | 128 | 98 | S ≤ 0.25, R > 0.25 |
| Moxifloxacinc | 32 | 32 | 130 | 100 | 4 |
| Rifampicinc | 32 | 32 | 83 | 64 | 0.004 |
| Piperacillin/Tazobactamd | 3 | 6 | 129 | 99 | S ≤ 0.5, R > 0.5 |
| Imipenemd | 32 | 32 | 129 | 99 | S ≤ 0.5, R > 0.5 |
| Benzylpenicillind | 1 | 2 | 108 | 83 | S ≤ 0.5, R > 0.5 |
| Chloramphenicole | 6 | 12 | 17 | 13 | S ≤ 8, R > 8 |
Resistance according to EUCAST (v.15 2024).
Assumed R > 256 mg/L.
ECOFF for C. difficile was used.
MICs for C. perfringens according to EUCAST 2024.
MICs for Gram-positive anaerobes were used because lack of them according EUCAST (v.11).